. In addition, sight-threatening retinopathy has emerged as an important complication that occurs from the second decade after diagnosis 6 . People with T1DM have decreased life expectancy compared with the background population [7] [8] [9] [10] . Moreover, individuals who develop diabetes at a younger age have worse outcomes than those with an older age of onset 11, 12 . In 2018, a US cohort study that used data derived from the National Health Interview Survey Linked Mortality Files indicated that, although all-cause mortality substantially declined between 1988-1994 infarction in early adulthood (mean age at follow-up 29 years) compared with peers without diabetes 12 . These findings have generated considerable concerns for parents and those caring for young people with T1DM. Overall, the findings reiterate the need for improved methods to identify patients at risk of complications and for better screening for complications and treatment strategies.
In this Perspective, we discuss the potential effect of recent findings (between 2009 and 2018) from cohorts of adolescents with T1DM on the role of urinary albumin excretion as a predictor of vascular complications. We then propose a new framework for patient risk stratification that is based on monitoring the albumin:creatinine ratio (ACR), HbA 1c levels and other risk factors to guide future recommendations for screening and interventions.
Glycaemic control The risk of vascular complications.
Adolescence is a high-risk period for the development of complications of T1DM, as optimal glycaemic control is difficult to achieve owing to the effect of hormonal changes and psychosocial factors 13, 14 . The first signs of vascular complications appear during adolescence, and subclinical manifestations are common; however, hard end points, such as overt proteinuria, proliferative retinopathy or cardiovascular events, are rare 15, 16 . Subclinical manifestations include early increases in urinary albumin excretion, changes in the retinal microvasculature and subclinical changes in large blood vessels, including increased arterial stiffness, aortic intima-media thickness (aIMT) and carotid intima-media thickness (cIMT) 15 ( Fig. 1 ).
Glycaemic control is the main modifiable risk factor for vascular complications, which is clearly defined by the Diabetes Control and Complications Trial (DCCT) and the follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC) 17, 18 . Only a small number (195 out of 1,441 total participants) of adolescents (aged 13-17 years) were included in the DCCT. In adolescents with T1DM, the beneficial effect of intensive therapy in reducing HbA 1c levels was similar to the adult cohort. However, the overall levels of HbA 1c were ~1% higher in adolescents than those observed in adults 17, 19 . and 2010-2015 in adults with T1DM older than 44 years of age, mortality remained almost unchanged in younger people with T1DM (aged 20-44 years) 11 . This observation has been further confirmed by the 2018 findings from the Swedish National Diabetes Register, which showed an excess mortality and cardiovascular disease risk in young adults (mean age 29 years) with T1DM that was related to the age at onset 12 . The results emphasized that diagnosis before the age of 10 years was associated with a loss of life expectancy from the general population mean of 17.7 years in women and 14.2 years in men, as compared with 10.1 years in women and 9.4 years in men diagnosed between the ages of 26 and 30 years 12 .
The Swedish study also showed that age at diagnosis has a striking effect on cardiovascular outcomes. Individuals diagnosed with T1DM before the age of 10 years have a 30-fold increased risk of coronary heart disease and acute myocardial Abstract | Diabetes vascular complications, including cardiovascular disease, diabetic nephropathy and retinopathy , have a negative effect on the long-term prognosis of young people with type 1 diabetes mellitus (T1DM). Poor glycaemic control and consequent increased HbA 1c levels are major risk factors for the development of vascular complications. HbA 1c levels are the main focus of current management strategies; however, the recommended target is rarely achieved in adolescents. Thus, a clear need exists for improved biomarkers to identify high-risk young people early and to develop new intervention strategies. Evidence is accumulating that early increases in urinary albumin excretion could be predictive of adolescents with T1DM who are at an increased risk of developing vascular complications, independent of HbA 1c levels. These findings present an opportunity to move towards the personalized care of adolescents with T1DM, which takes into consideration changes in albumin excretion and other risk factors in addition to HbA 1c levels. 21 , the National Institute of Clinical Excellence (<6.5% or 48 mmol per mol) 22 and other organizations 23 .
Improvements in management.
Ambitious targets for glycaemic control have been partly driven by considerable developments in the care and management of young people with T1DM 24, 25 . The most important developments have been in the monitoring of day-to-day changes in glucose levels using continuous glucose monitoring systems, refinements in insulin delivery with new insulin analogues and the increasing use of insulin pump therapy to improve insulin delivery 24 . Since 2010, further progress has been made with the introduction of closed-loop insulin delivery (also known as an artificial pancreas) that links glucose sensor data to a central algorithm, which improves the accuracy of insulin delivery 26 . Closed-loop insulin delivery may increase time in the target range for glucose levels, thereby preventing hyperglycaemia and avoiding hypoglycaemia 27 . Achieving the recommended glycaemic targets to reduce the risk of long-term complications remains a major challenge in adolescent populations with T1DM, as evidenced by data from the National Paediatric Diabetes Audit in the UK (28.9% of adolescents achieve HbA 1c target levels of <7.5%) 28 , the Australasian Diabetes Data Network (27% of adolescents achieve HbA 1c target levels) 29 and the T1D Exchange Registry in the US (17-23% of adolescents achieve HbA 1c target levels) 30 . These data raise the question as to whether, in addition to striving for improvements in HbA 1c levels, we should do more to prevent complications in children and adolescents with T1DM.
Age at diagnosis and duration
The duration of diabetes is closely linked to the risk of complications; however, several threads of evidence suggest that the age at diagnosis might also be an important non-modifiable risk factor [31] [32] [33] . Cohort studies have highlighted an increased risk of vascular complications (for example, microalbuminuria and retinopathy (Box 1)) that are associated with an early age at diagnosis (that is, during childhood or adolescence) compared with a diagnosis during adulthood 31, 34 . In the Oxford Regional Prospective Study (ORPS) cohort of children and adolescents with T1DM, the cumulative prevalence of microalbuminuria was 26% after 10 years duration and 51% after 19 years duration of diabetes 31 . By contrast, in a comparable adult cohort, the prevalence of microalbuminuria was 34% after 18 years duration of diabetes and exposure to similar levels of glycaemic control as in the ORPS cohort 35 . Interestingly, young people from the ORPS cohort who were diagnosed before puberty (between the ages of 0 and 10 years) showed a low prevalence of microalbuminuria until they reached puberty; thereafter, microalbuminuria prevalence increased 31 . By contrast, individuals diagnosed during puberty showed a consistent increased cumulative prevalence of microalbuminuria 31 . Notably, the risk of developing retinopathy is higher in people diagnosed before the age of 14 years than in those diagnosed during adulthood 34 . These data suggest that a diagnosis of T1DM made during childhood and adolescence might be associated with different risk factors for the development of complications when compared with a later diagnosis made during adult life.
Pubertal risk factors
During the pubertal years (~10-16 years of age), several factors other than glycaemic control, related to growth and hormonal changes, can contribute to the development of the early signs of vascular complications 33, [36] [37] [38] . These factors include abnormalities in the growth hormone (GH)-insulin-like growth factors 1 axis, androgens levels in girls, female sex and other risk factors, such as high blood pressure, dyslipidaemia, obesity, insulin resistance, inflammatory markers, renal hyperfiltration, smoking and a familial or genetic predisposition 33, 36 . In adolescents with T1DM, insulin resistance is a prominent feature, even in the absence of excess weight gain 39 . Moreover, insulin resistance can contribute to the increased risk of complications, such as microalbuminuria and abnormal cardiovascular markers [38] [39] [40] [41] [42] . Notably, a sexual dimorphism exists for the risk of complications during adolescence, with a higher percentage of girls developing microalbuminuria or retinopathy 31, 43 . By contrast men have a higher risk of complications during adulthood 35 . Adolescent girls with microalbuminuria had higher testosterone levels than matched control individuals without this complication 44 , suggesting that increased androgen production by the ovaries could contribute not only to the risk of polycystic ovary syndrome in girls with T1DM 45 but also to the female predominance of the early signs of vascular complications. Environmental influences and dietary factors, such as low adherence to healthy diets, might also contribute to the risk of developing complications during puberty and represent potential targets for interventions 36, 46 .
Albumin excretion as a biomarker
Microalbuminuria is the most frequently studied marker of the vascular complications of T1DM [47] [48] [49] . Although originally described as an early marker of incident diabetic nephropathy, the presence of microalbuminuria has also been associated with an increased risk of cardiovascular disease and is identified as a significant determinant of mortality in adults with T1DM 50 .
Adults with T1DM.
Longitudinal studies have shown that, in the absence of microalbuminuria, mortality in adults with T1DM is similar to that in the general population, whereas it substantially increases in individuals with increased urinary albumin excretion that falls above the cut-off for microalbuminuria 51, 52 . Meta-analyses from 2012 and 2015 indicate that even early increases in albumin excretion that fall within the normal range might predict renal and cardiovascular risk in adults with T1DM and in adults from the general population 53, 54 . Higher values of urinary albumin excretion within the normal range have been directly associated with increased risk of stroke, hypertension and early development of atherosclerosis as compared with lower values within the normal range 55 . A potential factor linking increased albumin excretion with renal and cardiovascular disease is endothelial dysfunction, which, in the context of diabetes, might be the initiating pathology leading to tissue and organ damage 56 . Together, these data suggest that in adults with T1DM, urinary albumin excretion should be considered a continuous risk factor for both renal and cardiovascular complications.
Young people with T1DM. Studies of adolescents with T1DM from longitudinal cohorts, such as the ORPS and Nephropathy Family Study (NFS), extended the findings from adult cohorts by providing longitudinal data from diagnosis that associates early increases in urinary ACR with a subsequent increased risk of the development of microalbuminuria 57, 58 (Fig. 2) . In young people who developed microalbuminuria and subsequently progressed to diabetic nephropathy, gradual increases in ACR occurred from diagnosis, which accelerated during puberty 57 and were associated with changes in blood pressure, lipid levels and inflammatory markers [59] [60] [61] . In individuals with high HbA 1c levels and therefore poor glycaemic control, ACR subsequently progressed after puberty, whereas those with good glycaemic control showed relative reductions in ACR 31 . Importantly, in the ORPS and NFS cohorts, using an algorithm that allowed adjustments of ACR for age, sex and duration of diabetes, an ACR in the upper tertile of the normal range at the age of 10-16 years was highly predictive of patients who later developed nephropathy. This predictive ability held true in young people with both persistent and intermittent changes in ACR 58 .
The AdDIT studies
Observations from early cohort studies on the relationship between adolescent urinary ACR and the risk of progression to diabetic nephropathy led to the design of the Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT) studies 62 . The rationale for the trial was that adolescents (aged 10-16 years old) who were in the highest tertile of ACR, but still fell below the cut-off for microalbuminuria, would probably be at greatest risk of complications and might benefit from 2-4 years of treatment with angiotensin-converting enzyme (ACE) inhibitors and/or statins to protect against renal, retinal and cardiovascular complications 63 . These drugs are indicated for use in adults with T1DM who have microalbuminuria 64 . The AdDIT protocol also included an observational untreated cohort of individuals who were deemed to be at low risk of complications on the basis of an ACR falling in the low and middle tertiles; these adolescents were also monitored over 2-4 years 65 (Fig. 3) . ACR tertiles. Screening for ACR in 4,407 adolescents with T1DM for the AdDIT studies confirmed the utility of a risk stratification system that is based on ACR tertiles. The tertiles were calculated from two sets of three consecutive early-morning urine samples collected at least 1 month apart. The median (interquartile ranges) unadjusted ACR levels were 0.52 (0.43-0.62) mg per mmol for the lower tertile, 0.71 (0.59-0.85) mg per mmol for the middle tertile and 1.24 (0.91-1.82) mg per mmol for the upper tertile 65 . For each study participant, ACR results were averaged on the log ACR scale and then standardized for sex, age and the duration of diabetes using a linear regression equation derived from the ORPS and NFS studies 58 . This method led to a cut-point greater than log1.2 to define the upper ACR tertile, between log0.8 and log1.2 to define the middle tertile and less than log0.8 to define the lower tertile.
In the AdDIT study, at baseline, adolescents in the highest tertile for ACR showed renal hyperfiltration, dyslipidaemia, early retinal vessel abnormalities and increased pulse wave velocity 65, 66 . In a subgroup of the AdDIT cohort, in which data on aIMT and autonomic function measures were available, a higher ACR at baseline was also associated with thicker aIMT and the presence of markers of autonomic dysfunction 67, 68 . However, despite these substantial differences in early vascular markers, there were minimal differences in HbA 1c levels across the ACR tertiles, which suggests that the risk of renal, retinal and cardiovascular complications may be partly independent of glycaemic control 65 . The results of both the AdDIT intervention and the AdDIT observational studies have now been published 63, 65, 66, 69 , and it is important to consider how these results could influence screening and intervention strategies in high-risk and low-risk adolescents with T1DM.
AdDIT intervention study. As previously mentioned, in adults with T1DM, the presence of microalbuminuria is a general indication for intervention with ACE inhibitors or angiotensin receptor blockers and for the consideration of statin therapy 64 . On the basis of the published data in adults with T1DM 70 , we predicted that intervention with ACE inhibitors might reduce the incidence of microalbuminuria in adolescents with T1DM. In addition, on the basis of positive results in young people with familial hypercholesterolaemia 71 , we expected that statins would reduce exposure to hyperlipidaemia in adolescents with T1DM 62 . In the AdDIT intervention study, both these predictions proved to be true and both drugs were well tolerated during adolescence with very few adverse effects 63 . In the adolescent AdDIT intervention cohort with ACR in the upper tertile, statin treatment resulted in substantial decreases in total cholesterol, LDL cholesterol and non-HDL cholesterol; decreases in the apolipoprotein B:apolipoprotein A ratio; and decreases in high-sensitivity C-reactive protein (hsCRP) 63 , which might lead to a long-term reduction in cardiovascular risk. In addition, adolescents with T1DM from the AdDIT cohort who were treated with ACE inhibitors showed a trend towards a reduction in the prevalence of microalbuminuria, including cases of intermittent microalbuminuria 63 . This intervention could therefore lead to a long-term reduced risk of progression to diabetic nephropathy and prevention of cardiovascular disease This graph shows the design of the Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT) studies, starting from the screening phase and followed by stratification of eligible participants into tertiles of albumin:creatinine ratio (ACR). In this study , 443 adolescents with an ACR in the upper tertile (high-ACR group) entered the AdDIT randomized clinical trial and were treated with an angiotensin-converting enzyme (ACE) inhibitor and placebo, a statin and a placebo or a combination of both drugs or placebos, whereas 400 adolescents with an ACR either in the lower or middle tertile (low-ACR group) were recruited into the AdDIT observational study. Assessments performed at baseline and during the follow-up period (duration 2-4 years) are reported. cIMT, carotid intima-media thickness; FMD, flow-mediated dilation; hsCRP, high-sensitivity C-reactive protein; PWV, pulse wave velocity ; T1DM, type 1 diabetes mellitus. which is well above the average adherence in other trials with adolescent populations 73 , and both drugs were safe. These results are encouraging and suggest that statins and ACE inhibitors might be used more widely in individuals with T1DM from a younger age.
Importantly, the AdDIT intervention study failed to show an effect on the primary outcome, which was whether either ACE inhibitors or statins alone or in combination could reduce the baseline ACR in adolescents with T1DM and thus potentially reduce the ACR-associated risk of progression to diabetic nephropathy and cardiovascular disease 63 . In retrospect, this primary outcome was potentially naive, as subsequent analysis of the AdDIT data suggests that the inherent risk of complications that is associated with high baseline ACR may be more closely related to genetic or environmental factors, which are unlikely to be influenced by these drugs 69 .
The lack of effect of ACE inhibitors and statins in the AdDIT population on the primary outcome along with the known modulatory effect of other factors on albumin excretion during puberty 33, 36, 37 suggest that additional interventions might be necessary to affect other mechanisms that are implicated in the pathogenesis of vascular complications during adolescence. These interventions could include new drugs as well as lifestyle changes to control weight gain and improve insulin sensitivity.
AdDIT observational cohort. Subsequent studies of the observational AdDIT cohort and those participants in the interventional cohort who were randomized to the placebo arm provided further insights into the predictive value of ACR 69 . During the 2-4-year observational period, we noted substantial differences between adolescents with a high baseline ACR and those with a low baseline ACR (falling in the middle and lower tertiles). Individuals with high baseline ACR were more likely to develop microalbuminuria but also had more marked increases in cIMT, hsCRP and systolic blood pressure, which are indicative of future risk of both diabetic nephropathy and cardiovascular disease 69 . Notably, the greatest risk of progression of retinopathy was also observed in those in the highest tertile of ACR 74 . Importantly, all these observations were partly independent of HbA 1c (reFs 69, 74 ), which suggests that other pathogenic mechanisms in addition to the effect of glycaemic control are responsible for the vascular complications of diabetes (Fig. 4) . Together, these data suggest that repeated measures of ACR between the ages of 10 and 16 years could contribute additional prognostic information for young people with early-onset T1DM. In the future, these findings could lead to precision medicine approaches for intensifying therapy on the basis of HbA 1c levels and additional potential markers of the risk of complications such as ACR.
A change in risk assessment? Current guidelines. During adolescence, the primary focuses of management of the risk of diabetes complications are improvements in glycaemic control and decreases in HbA 1c (reFs 20, 21 ), although the recommended target levels for HbA 1C are difficult to achieve 29, 30 . Current guidelines also recommend regular screening for microalbuminuria (as a marker of incident nephropathy) and dyslipidaemia and hypertension (as markers of potential cardiovascular disease) from the ages of 10 to 11 years 20, 21 . However, the current recommendations for appropriate interventions are still vague as there are few published outcome data.
The various existing clinical guidelines that recommend screening during adolescence for microalbuminuria differ only slightly in the advised age at screening; however, current guidelines only broadly describe the method of screening and interpretation of the results [20] [21] [22] . In the various guidelines, microalbuminuria is usually defined as two out of three urine collections that exceed a sex-specific value of ACR (Box 1). Only individuals who are classified as having developed microalbuminuria are subsequently investigated for evidence of abnormalities in ambulatory blood pressure and may be started on an ACE inhibitor 20, 21 .
A new proposed approach. Data from ORPS, NFS and AdDIT suggest that the above-described approach advised in clinical guidelines for detecting or excluding incident nephropathy might not identify all young people at risk of diabetic nephropathy, cardiovascular disease and retinopathy. Urinary albumin excretion is highly variable, and the single measurement made in three urine samples every year might fail to detect people who have increasing albumin excretion. These individuals with increasing albumin excretion need to be identified through repeated measures of ACR. The AdDIT results suggest that accurately tracking urinary albumin excretion using two sets of three repeated measurements of ACR annually from as early as 10 years of age can help in identifying those adolescents with increased risk of future complications 69 . These data could be used alongside HbA 1c levels to determine the relative risk of complications, which could then be used to influence management. Those adolescents with a rapidly increasing ACR during clinical follow-up and poor glycaemic control would be the priority targets for intensive insulin therapy but also potentially volume 15 | JulY 2019 | 433 NATuRe RevIewS | EnDoCRInology P e r s P e c t i v e s for treatment with ACE inhibitors or angiotensin receptor blockers. Data from the AdDIT trial have also provided support for the wider use of statins in young people (>10 years of age) with T1DM in whom high lipid levels are detected. The studies provided reassuring safety data for this patient population, which are similar to those previously reported in children and adolescents with familial hypercholesterolaemia 75 . Furthermore, these high-risk young individuals might be potential candidates for new reno-protective drugs, such as sodiumglucose cotransporter 2 inhibitors, which have shown promising results in terms of cardio-renal outcomes in adults with diabetes 76 . We plan further analyses of the large AdDIT data set to refine the ACR-based algorithm for the identification of adolescents who are at higher risk of renal, retinal and cardiovascular outcomes. We will explore interactions between HbA 1c and other biomarkers, such as lipids, blood pressure, BMI, glomerular filtration rate, inflammatory markers and new biomarkers emerging from ongoing 'omics' studies. Further follow-up of the AdDIT cohort during adult life will also provide valuable information on the rates of long-term complications and hard end points and how these outcomes might be influenced by early interventions during the critical pubertal years. Even small reductions in HbA 1c , blood pressure, lipid levels, inflammatory markers and the rate of microalbuminuria during the AdDIT trial period could lead to longer-term cardio-renal protection.
Conclusions
Data from historical cohorts of children and adolescents with T1DM and the more recent AdDIT cohort provide evidence that variation in urinary albumin excretion, in patients aged 10-16 years, can predict future risk of vascular complications. These findings support the concept that risk stratification using ACR during early adolescence might be critical for the early identification of patients who are at risk of developing renal, retinal and cardiovascular complications.
In our opinion, detailed assessment and tracking of ACR, considered together with other risk factors during adolescence, could be used in addition to HbA 1c to identify young people who are most at risk. This information might be used to guide future management and support prevention strategies in adolescents with T1DM based on precision medicine. 
